Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Zhongshan Hospital, FuDan University, Shanghai, Shanghai Municipality, China

    Contact: Principal Investigator (Tianshu Liu)